<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/ct2/show/NCT02988453</url>
  </required_header>
  <id_info>
    <org_study_id>23011229</org_study_id>
    <nct_id>NCT02988453</nct_id>
  </id_info>
  <brief_title>Mentalization-based Training for Adolescents With Conduct Disorder (MBT-CD)</brief_title>
  <acronym>MBT-CD</acronym>
  <official_title>Mentalization-based Training for Adolescents With Conduct Disorder (MBT-CD): A Feasibility and Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heidelberg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Heidelberg University, Psychotherapy Research Department</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Heidelberg University, Clinic for Child and Youth Psychiatry</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johannes Gutenberg University Mainz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Heidelberg University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A feasibility and pilot trial to investigate the feasibility of a newly manualized&#xD;
      psychotherapy &quot;Mentalization-Based Training for Adolescents with Conduct Disorder (MBT-CD)&quot;&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Conduct Disorder is a severe and complex mental disorder with the highest&#xD;
      incidence in adolescence. Previous studies have shown that family-oriented interventions are&#xD;
      effective in the treatment of Conduct Disorder. However, most therapies focus rather on&#xD;
      symptom management and less on etiological causes without inclusion of the family in the&#xD;
      therapeutic process. Previous research has linked specific symptoms of Conduct Disorder with&#xD;
      deficits in mentalization ability. Mentalization is the ability to perceive one's own and&#xD;
      other's behavior as the product of affective and cognitive mental states. Low or missing&#xD;
      mentalization abilities are regarded as a risk factor for the development and chronification&#xD;
      of Conduct Disorder.&#xD;
&#xD;
      Aims: The study aims to investigate the feasibility of a newly manualized psychotherapy&#xD;
      &quot;Mentalization-Based Training for Adolescents with Conduct Disorder (MBT-CD)&quot; that strives to&#xD;
      decrease symptoms associated with Conduct Disorder by increasing mentalization in adolescents&#xD;
      and their families.&#xD;
&#xD;
      Methods: The study is feasibility and piolot trial, carried out in Heidelberg (Germany), and&#xD;
      Mainz (Germany). Adolescents aged between 11-18, who meet the DSM-5 criteria for Conduct&#xD;
      Disorder will receive MBT-CD. Times of measurement: t0 (Screening), T1 (Baseline, at the&#xD;
      beginning of therapy), T2 (3 months after the beginning of therapy), T3 (at the end of&#xD;
      therapy, after 6 months), T4 (follow-up, after 9 months).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Actual">December 2021</completion_date>
  <primary_completion_date type="Actual">October 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Structured Clinical Interview for DSM-IV Axis II Disorders (SCID-II)</measure>
    <time_frame>Change from baseline in SCID-II at 12 months (at the end of therapy)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Subtypes of Antisocial Behaviour Questionnaire (STAB)</measure>
    <time_frame>Change from baseline in STAB at 6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Subtypes of Antisocial Behaviour Questionnaire (STAB)</measure>
    <time_frame>Change from baseline in STAB at 12 months (at the end of therapy)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Subtypes of Antisocial Behaviour Questionnaire (STAB)</measure>
    <time_frame>Change from baseline in STAB at 18 months (follow-up)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Reactive-Proactive-Aggression Questionnaire (RPQ)</measure>
    <time_frame>Change from baseline in RPQ at 6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Reactive-Proactive-Aggression Questionnaire (RPQ)</measure>
    <time_frame>Change from baseline in RPQ at 12 months (at the end of therapy)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Reactive-Proactive-Aggression Questionnaire (RPQ)</measure>
    <time_frame>Change from baseline in RPQ at 18 months (follow-up)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Global Assessment of Functioning (GAF)</measure>
    <time_frame>Change from baseline in GAF at 12 months (at the end of therapy)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Global Impression (CGI-SI)</measure>
    <time_frame>Change from baseline in CGI-SI at 12 months (at the end of therapy)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Levels of Personality Functioning - Questionnaire Adolescence (LoPF-QA)</measure>
    <time_frame>Change from baseline in LoPF-QA at 12 months (at the end of therapy)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Levels of Personality Functioning - Questionnaire Adolescence (LoPF-QA)</measure>
    <time_frame>Change from baseline in LoPF-QA at 18 months (follow-up)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reflective Functioning Questionnaire (RFQ)</measure>
    <time_frame>Change from baseline in RFQ at 12 months (at the end of therapy)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reflective Functioning Questionnaire (RFQ)</measure>
    <time_frame>Change from baseline in RFQ at 18 months (follow-up)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Movie for the Assessment of Social Cognition (MASC)</measure>
    <time_frame>Change from baseline in MASC at 12 months (at the end of therapy)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>10 round Trust Game Task (TGT)</measure>
    <time_frame>Change from baseline in TGT at 12 months (at the end of therapy)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Social Hierarchy Task (SHT)</measure>
    <time_frame>Change from baseline in SHT at 12 months (at the end of therapy)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Approach-Avoidance Task (AAT)</measure>
    <time_frame>Change from baseline in AAT at 12 months (at the end of therapy)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptom Checklist-90-Revised (SCL-90R)</measure>
    <time_frame>Change from baseline in SCL-90R at 12 months (at the end of therapy)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stress Index for Parents of Adolescents (SIPA)</measure>
    <time_frame>Change from baseline in SIPA at 12 months (at the end of therapy)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stress Index for Parents of Adolescents (SIPA)</measure>
    <time_frame>Change from baseline in SIPA at 18 months (follow-up)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>drop-out rates</measure>
    <time_frame>after 12 months (at the end of therapy)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cost-effectiveness</measure>
    <time_frame>after 12 months (at the end of therapy)</time_frame>
    <description>Cost-effectiveness will be measured by participation in training/school, rehospitalization, internment</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Working Alliance Inventory (WAI)</measure>
    <time_frame>Change from baseline in WAI at 6 months</time_frame>
    <description>Treatment related variable (moderator)</description>
  </other_outcome>
  <other_outcome>
    <measure>Working Alliance Inventory (WAI)</measure>
    <time_frame>Change from baseline in WAI at 12 months (at the end of therapy)</time_frame>
    <description>Treatment related variable (moderator)</description>
  </other_outcome>
  <other_outcome>
    <measure>Experiences in Close Relationships - Revised (ECR-R)</measure>
    <time_frame>Change from baseline in ECR-R at 12 months (at the end of therapy)</time_frame>
    <description>Treatment related variable (moderator)</description>
  </other_outcome>
  <other_outcome>
    <measure>Emotion Regulation Questionnaire (ERQ)</measure>
    <time_frame>Change from baseline in ERQ at 12 months (at the end of therapy)</time_frame>
    <description>Treatment related variable (moderator)</description>
  </other_outcome>
  <other_outcome>
    <measure>Emotion Regulation Questionnaire (ERQ)</measure>
    <time_frame>Change from baseline in ERQ at 18 months (follow-up)</time_frame>
    <description>Treatment related variable (moderator)</description>
  </other_outcome>
  <other_outcome>
    <measure>Zurich Brief Questionnaire for the Assessment of Parental Behaviors (ZKE)</measure>
    <time_frame>Change from baseline in ZKE at 12 months (at the end of therapy)</time_frame>
    <description>Treatment related variable (moderator)</description>
  </other_outcome>
  <other_outcome>
    <measure>The Mini-International Neuropsychiatric Interview (MINI)</measure>
    <time_frame>Change from baseline in MINI at 12 months (at the end of therapy)</time_frame>
    <description>Treatment related variable (moderator)</description>
  </other_outcome>
  <other_outcome>
    <measure>Youth Psychopathy Traits Inventory (YPI)</measure>
    <time_frame>only baseline assessment</time_frame>
    <description>Treatment related variable (moderator)</description>
  </other_outcome>
  <other_outcome>
    <measure>Cultural-Fair-Test (CFT-2)</measure>
    <time_frame>only baseline assessment</time_frame>
    <description>Treatment related variable (moderator)</description>
  </other_outcome>
  <other_outcome>
    <measure>Childhood Experience of Care and Abuse Questionnaire (CECA-Q)</measure>
    <time_frame>only baseline assessment</time_frame>
    <description>Treatment related variable (moderator)</description>
  </other_outcome>
  <other_outcome>
    <measure>Dimensional Assessment of Personality Pathology - Basic Questionnaire (DAPP-BQ)</measure>
    <time_frame>only baseline assessment</time_frame>
    <description>Treatment related variable (moderator)</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Conduct Disorder</condition>
  <arm_group>
    <arm_group_label>MBT-CD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mentalization-based treatment program</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MBT-CD</intervention_name>
    <description>MBT-CD is a disorder-specific modification of MBT, initially developed for patients with Borderline Personality Disorder. It is a manualized and psychodynamically oriented psychotherapy with the aim to increase the mentalization capacity of adolescents in close relationships. The therapy consists of 2 psychoeducational group sessions, 30 individual therapy sessions and 10 family sessions. The average duration of therapy is 6 months.</description>
    <arm_group_label>MBT-CD</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  main diagnosis conduct disorder (DSM-5 312.81,312.82)&#xD;
&#xD;
          -  written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  acute substance dependence&#xD;
&#xD;
          -  sexual offenses&#xD;
&#xD;
          -  acute psychotic symptoms, early or early-onset schizophrenia&#xD;
&#xD;
          -  neurological impairments and low intelligence (IQ &lt;80)&#xD;
&#xD;
          -  non-German-speaking&#xD;
&#xD;
          -  other clinical contra indication for outpatient psychotherapy (e.g. acute suicidality)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>11 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Svenja Taubner, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute for Psychosocial Prevention, Heidelberg University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Heidelberg University</name>
      <address>
        <city>Heidelberg</city>
        <zip>69115</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Taubner S, Zimmermann L, Ramberg A, Schroder P. Mentalization Mediates the Relationship between Early Maltreatment and Potential for Violence in Adolescence. Psychopathology. 2016;49(4):236-246. doi: 10.1159/000448053. Epub 2016 Aug 23.</citation>
    <PMID>27548462</PMID>
  </reference>
  <reference>
    <citation>Rossouw TI, Fonagy P. Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry. 2012 Dec;51(12):1304-1313.e3. doi: 10.1016/j.jaac.2012.09.018.</citation>
    <PMID>23200287</PMID>
  </reference>
  <reference>
    <citation>Taubner S, White LO, Zimmermann J, Fonagy P, Nolte T. Attachment-related mentalization moderates the relationship between psychopathic traits and proactive aggression in adolescence. J Abnorm Child Psychol. 2013 Aug;41(6):929-38. doi: 10.1007/s10802-013-9736-x.</citation>
    <PMID>23512713</PMID>
  </reference>
  <reference>
    <citation>McGauley G, Yakeley J, Williams W, Bateman AW. Attachment, mentalization and antisocial personality disorder. The possible contribution of mentalization-based treatment. European Journal of Psychotherapy &amp; Counselling. 2011; 13 (4): 371-393; doi: 10.1080/13642537.2011.629118.</citation>
  </reference>
  <verification_date>May 2022</verification_date>
  <study_first_submitted>November 30, 2016</study_first_submitted>
  <study_first_submitted_qc>December 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2016</study_first_posted>
  <last_update_submitted>May 17, 2022</last_update_submitted>
  <last_update_submitted_qc>May 17, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heidelberg University</investigator_affiliation>
    <investigator_full_name>Svenja Taubner</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>mentalization-based treatment</keyword>
  <keyword>conduct disorder</keyword>
  <keyword>adolescents</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Conduct Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>


download date: ClinicalTrials.gov processed this data on September 20, 2023
link text: Link to the current ClinicalTrials.gov record.
url: https://clinicaltrials.gov/ct2/show/NCT02988453
org study id: 23011229
nct id: NCT02988453
lead sponsor: 
collaborator: 
collaborator: 
collaborator: 
has dmc: No
A feasibility and pilot trial to investigate the feasibility of a newly manualized
      psychotherapy "Mentalization-Based Training for Adolescents with Conduct Disorder (MBT-CD)"
Background: Conduct Disorder is a severe and complex mental disorder with the highest
      incidence in adolescence. Previous studies have shown that family-oriented interventions are
      effective in the treatment of Conduct Disorder. However, most therapies focus rather on
      symptom management and less on etiological causes without inclusion of the family in the
      therapeutic process. Previous research has linked specific symptoms of Conduct Disorder with
      deficits in mentalization ability. Mentalization is the ability to perceive one's own and
      other's behavior as the product of affective and cognitive mental states. Low or missing
      mentalization abilities are regarded as a risk factor for the development and chronification
      of Conduct Disorder.

      Aims: The study aims to investigate the feasibility of a newly manualized psychotherapy
      "Mentalization-Based Training for Adolescents with Conduct Disorder (MBT-CD)" that strives to
      decrease symptoms associated with Conduct Disorder by increasing mentalization in adolescents
      and their families.

      Methods: The study is feasibility and piolot trial, carried out in Heidelberg (Germany), and
      Mainz (Germany). Adolescents aged between 11-18, who meet the DSM-5 criteria for Conduct
      Disorder will receive MBT-CD. Times of measurement: t0 (Screening), T1 (Baseline, at the
      beginning of therapy), T2 (3 months after the beginning of therapy), T3 (at the end of
      therapy, after 6 months), T4 (follow-up, after 9 months).
allocation: N/A
intervention model: Single Group Assignment
primary purpose: Treatment
masking: None (Open Label)
measure: Structured Clinical Interview for DSM-IV Axis II Disorders (SCID-II)
time frame: Change from baseline in SCID-II at 12 months (at the end of therapy)
measure: Subtypes of Antisocial Behaviour Questionnaire (STAB)
time frame: Change from baseline in STAB at 6 months
measure: Subtypes of Antisocial Behaviour Questionnaire (STAB)
time frame: Change from baseline in STAB at 12 months (at the end of therapy)
measure: Subtypes of Antisocial Behaviour Questionnaire (STAB)
time frame: Change from baseline in STAB at 18 months (follow-up)
measure: Reactive-Proactive-Aggression Questionnaire (RPQ)
time frame: Change from baseline in RPQ at 6 months
measure: Reactive-Proactive-Aggression Questionnaire (RPQ)
time frame: Change from baseline in RPQ at 12 months (at the end of therapy)
measure: Reactive-Proactive-Aggression Questionnaire (RPQ)
time frame: Change from baseline in RPQ at 18 months (follow-up)
measure: Global Assessment of Functioning (GAF)
time frame: Change from baseline in GAF at 12 months (at the end of therapy)
measure: Clinical Global Impression (CGI-SI)
time frame: Change from baseline in CGI-SI at 12 months (at the end of therapy)
measure: Levels of Personality Functioning - Questionnaire Adolescence (LoPF-QA)
time frame: Change from baseline in LoPF-QA at 12 months (at the end of therapy)
measure: Levels of Personality Functioning - Questionnaire Adolescence (LoPF-QA)
time frame: Change from baseline in LoPF-QA at 18 months (follow-up)
measure: Reflective Functioning Questionnaire (RFQ)
time frame: Change from baseline in RFQ at 12 months (at the end of therapy)
measure: Reflective Functioning Questionnaire (RFQ)
time frame: Change from baseline in RFQ at 18 months (follow-up)
measure: Movie for the Assessment of Social Cognition (MASC)
time frame: Change from baseline in MASC at 12 months (at the end of therapy)
measure: 10 round Trust Game Task (TGT)
time frame: Change from baseline in TGT at 12 months (at the end of therapy)
measure: Social Hierarchy Task (SHT)
time frame: Change from baseline in SHT at 12 months (at the end of therapy)
measure: Approach-Avoidance Task (AAT)
time frame: Change from baseline in AAT at 12 months (at the end of therapy)
measure: Symptom Checklist-90-Revised (SCL-90R)
time frame: Change from baseline in SCL-90R at 12 months (at the end of therapy)
measure: Stress Index for Parents of Adolescents (SIPA)
time frame: Change from baseline in SIPA at 12 months (at the end of therapy)
measure: Stress Index for Parents of Adolescents (SIPA)
time frame: Change from baseline in SIPA at 18 months (follow-up)
measure: drop-out rates
time frame: after 12 months (at the end of therapy)
measure: cost-effectiveness
time frame: after 12 months (at the end of therapy)
description: Cost-effectiveness will be measured by participation in training/school, rehospitalization, internment
measure: Working Alliance Inventory (WAI)
time frame: Change from baseline in WAI at 6 months
description: Treatment related variable (moderator)
measure: Working Alliance Inventory (WAI)
time frame: Change from baseline in WAI at 12 months (at the end of therapy)
description: Treatment related variable (moderator)
measure: Experiences in Close Relationships - Revised (ECR-R)
time frame: Change from baseline in ECR-R at 12 months (at the end of therapy)
description: Treatment related variable (moderator)
measure: Emotion Regulation Questionnaire (ERQ)
time frame: Change from baseline in ERQ at 12 months (at the end of therapy)
description: Treatment related variable (moderator)
measure: Emotion Regulation Questionnaire (ERQ)
time frame: Change from baseline in ERQ at 18 months (follow-up)
description: Treatment related variable (moderator)
measure: Zurich Brief Questionnaire for the Assessment of Parental Behaviors (ZKE)
time frame: Change from baseline in ZKE at 12 months (at the end of therapy)
description: Treatment related variable (moderator)
measure: The Mini-International Neuropsychiatric Interview (MINI)
time frame: Change from baseline in MINI at 12 months (at the end of therapy)
description: Treatment related variable (moderator)
measure: Youth Psychopathy Traits Inventory (YPI)
time frame: only baseline assessment
description: Treatment related variable (moderator)
measure: Cultural-Fair-Test (CFT-2)
time frame: only baseline assessment
description: Treatment related variable (moderator)
measure: Childhood Experience of Care and Abuse Questionnaire (CECA-Q)
time frame: only baseline assessment
description: Treatment related variable (moderator)
measure: Dimensional Assessment of Personality Pathology - Basic Questionnaire (DAPP-BQ)
time frame: only baseline assessment
description: Treatment related variable (moderator)
arm group label: MBT-CD
arm group type: Experimental
description: Mentalization-based treatment program
intervention type: Other
intervention name: MBT-CD
description: MBT-CD is a disorder-specific modification of MBT, initially developed for patients with Borderline Personality Disorder. It is a manualized and psychodynamically oriented psychotherapy with the aim to increase the mentalization capacity of adolescents in close relationships. The therapy consists of 2 psychoeducational group sessions, 30 individual therapy sessions and 10 family sessions. The average duration of therapy is 6 months.
arm group label: MBT-CD
criteria: 
gender: All
minimum age: 11 Years
maximum age: 18 Years
healthy volunteers: No
last name: Svenja Taubner, Prof.
role: Principal Investigator
affiliation: Institute for Psychosocial Prevention, Heidelberg University
facility: 
country: Germany
citation: Taubner S, Zimmermann L, Ramberg A, Schroder P. Mentalization Mediates the Relationship between Early Maltreatment and Potential for Violence in Adolescence. Psychopathology. 2016;49(4):236-246. doi: 10.1159/000448053. Epub 2016 Aug 23.
PMID: 27548462
citation: Rossouw TI, Fonagy P. Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry. 2012 Dec;51(12):1304-1313.e3. doi: 10.1016/j.jaac.2012.09.018.
PMID: 23200287
citation: Taubner S, White LO, Zimmermann J, Fonagy P, Nolte T. Attachment-related mentalization moderates the relationship between psychopathic traits and proactive aggression in adolescence. J Abnorm Child Psychol. 2013 Aug;41(6):929-38. doi: 10.1007/s10802-013-9736-x.
PMID: 23512713
citation: McGauley G, Yakeley J, Williams W, Bateman AW. Attachment, mentalization and antisocial personality disorder. The possible contribution of mentalization-based treatment. European Journal of Psychotherapy & Counselling. 2011; 13 (4): 371-393; doi: 10.1080/13642537.2011.629118.
responsible party type: Principal Investigator
investigator affiliation: Heidelberg University
investigator full name: Svenja Taubner
investigator title: Prof. Dr.
mesh term: Conduct Disorder
sharing ipd: No